|
Albert Graham,
Backyard Pool Drainer
|
Most small cell lung cancers have absent or abnormal RB protein.
Non-small-cell lung cancer usually spreads to other parts of the body more slowly than small-cell lung cancer.
Non-small cell lung cancer (NSCLC) is one of the most difficult cancers to treat, particularly when it spreads to the lining of the chest cavity.
|
|
Zhang Xian Qian,
Ex-Olympic Swimmer
|
Non small cell lung cancers (the largest type of lung cancer) are classified from stage 1 to stage 4.
Gefitinib was approved first in Japan for the treatment of inoperable or recurrent non-small cell lung cancer (NSCLC) in July 2002.
|
|
Dave Simons,
Internet Entrepeneur
|
Lung – Non-small Cell Cancer Profiler, NexCura and the NexCura logo are either trademarks or registered trademarks of NexCura, Inc.
|
|
Arthur Dawkins,
Astro-physicist
|
Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials.
Agent is able to detect protein found on the surface of most small cell lung cancers and is used as a diagnostic tool on patients who have biopsy-confirmed tumors.
Survival of Patients with Limited Stage Small Cell Lung Cancer Treated with Individualized Chemotherapy Selected by In Vitro Drug Sensitivity Testing.
|
|
David Rosenberg,
Dermatologist
|
Chemotherapy is highly effective with small cell lung cancers promptly diagnosed, since this type of cancer rapidly divides.
The non-small-cell composes the majority of the lung cancers and is subdivided into several types based on the pathology and they are treated in the same fashion.
In small cell lung cancer, the majority of patients die of their tumor despite state-of-the-art treatment.
|
|
|
